Prevention of mother-to-child transmission of human T-lymphotropic virus type-I

Pediatrics. 1990 Jul;86(1):11-7.

Abstract

Human T-cell lymphotropic virus type I (HTLV-I), an etiologic human retrovirus of adult T-cell leukemia/lymphoma (ATLL), causes approximately 60 new cases of ATLL each year in Nagasaki Prefecture; essentially all cases are fatal, and they account for approximately 0.5% of total deaths in the area. The estimated life risk for an HTLV-I carrier to develop ATLL is approximately 5%. The major transmission pathway of HTLV-I peculiarly endemic in the Nagasaki Prefecture was studied. The prevalence of HTLV-I infection in children of carrier mothers (21%) was significantly higher than that in children in the general population in the area (1%) and more than 85% of mothers of carrier children were carriers. The breast milk of carrier mothers contained HTLV-I-infected cells and was infectious for marmoset via oral administration. A retrospective survey of children of carrier mothers showed that the prevalence of carrier children of carrier mothers was 17 (39%) of 44 and 0 (0%) of 10 when they were given breast milk only or formula only, respectively. These data provide a powerful basis for devising an intervention measure to block the endemic cycle of HTLV-I, ie, if carrier mothers refrain from breast-feeding, the incidence of ATLL will be significantly reduced some 50 years later.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Breast Feeding
  • Carrier State / epidemiology
  • Carrier State / transmission
  • Child
  • Child, Preschool
  • Female
  • HTLV-I Antibodies / blood
  • HTLV-I Infections / epidemiology
  • HTLV-I Infections / prevention & control*
  • HTLV-I Infections / transmission
  • Humans
  • Infant
  • Infant, Newborn
  • Japan / epidemiology
  • Leukemia-Lymphoma, Adult T-Cell / epidemiology
  • Leukemia-Lymphoma, Adult T-Cell / prevention & control
  • Leukemia-Lymphoma, Adult T-Cell / transmission
  • Pregnancy
  • Prevalence
  • Retrospective Studies
  • Seroepidemiologic Studies
  • Urban Population / statistics & numerical data

Substances

  • HTLV-I Antibodies